Visit COVID-19 resources

[Skip to Content]

Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sjögren’s syndrome – (Eye Journal AOP)

10 July 2015

This news item is available to RCOphth members only, please log in below to access.

Members Login